Cleton FJ - Search Results

1

Myocardial injury after interleukin-2 therapy.

Osanto S, Cluitmans FH, Franks CR, Bosker HA, Cleton FJ. Osanto S, et al. Among authors: cleton fj. Lancet. 1988 Jul 2;2(8601):48-9. doi: 10.1016/s0140-6736(88)92982-0. Lancet. 1988. PMID: 2898655 No abstract available.

2

[Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells].

Osanto S, Brand A, van Rood JJ, Cleton FJ. Osanto S, et al. Among authors: cleton fj. Ned Tijdschr Geneeskd. 1989 Jul 15;133(28):1392-5. Ned Tijdschr Geneeskd. 1989. PMID: 2677758 Review. Dutch. No abstract available.

3

Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study.

Stoter G, Aamdal S, Rodenhuis S, Cleton FJ, Iacobelli S, Franks CR, Oskam R, Shiloni E. Stoter G, et al. Among authors: cleton fj. J Clin Oncol. 1991 Sep;9(9):1687-91. doi: 10.1200/JCO.1991.9.9.1687. J Clin Oncol. 1991. PMID: 1875225 Clinical Trial.

4

Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma. A multicentre phase II study.

Stoter G, Shiloni E, Aamdal S, Cleton FJ, Iacobelli S, Bijman JT, Palmer P, Franks CR, Rodenhuis S. Stoter G, et al. Among authors: cleton fj. Eur J Cancer Clin Oncol. 1989;25 Suppl 3:S41-3. Eur J Cancer Clin Oncol. 1989. PMID: 2697578 Clinical Trial.

5

Alternating recombinant human interleukin-2 and dacarbazine in advanced melanoma. A multicentric phase II study.

Stoter G, Shiloni E, Gundersen S, Cleton FJ, Iacobelli S, Bijman JT, Palmer P, Franks CR, Rodenhuis S. Stoter G, et al. Among authors: cleton fj. Cancer Treat Rev. 1989 Jun;16 Suppl A:59-63. doi: 10.1016/0305-7372(89)90024-8. Cancer Treat Rev. 1989. PMID: 2788507 No abstract available.

6

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment.

Weijl NI, Van der Harst D, Brand A, Kooy Y, Van Luxemburg S, Schroder J, Lentjes E, Van Rood JJ, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: cleton fj. J Clin Oncol. 1993 Jul;11(7):1376-83. doi: 10.1200/JCO.1993.11.7.1376. J Clin Oncol. 1993. PMID: 8315436 Clinical Trial.

7

In vivo effects of combination treatment with recombinant interferon-gamma and -alpha in metastatic melanoma.

Osanto S, Jansen R, Naipal AM, Gratama JW, van Leeuwen A, Cleton FJ. Osanto S, et al. Among authors: cleton fj. Int J Cancer. 1989 Jun 15;43(6):1001-6. doi: 10.1002/ijc.2910430608. Int J Cancer. 1989. PMID: 2499552 Clinical Trial.

8

Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line.

Osanto S, Schiphorst PP, Weijl NI, Dijkstra N, Van Wees A, Brouwenstein N, Vaessen N, Van Krieken JH, Hermans J, Cleton FJ, Schrier PI. Osanto S, et al. Among authors: cleton fj. Hum Gene Ther. 2000 Mar 20;11(5):739-50. doi: 10.1089/10430340050015635. Hum Gene Ther. 2000. PMID: 10757353 Clinical Trial.

9

Free radicals and antioxidants in chemotherapy-induced toxicity.

Weijl NI, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: cleton fj. Cancer Treat Rev. 1997 Jul;23(4):209-40. doi: 10.1016/s0305-7372(97)90012-8. Cancer Treat Rev. 1997. PMID: 9377594 Review. No abstract available.

10

Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.

Weijl NI, Rutten MF, Zwinderman AH, Keizer HJ, Nooy MA, Rosendaal FR, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: cleton fj. J Clin Oncol. 2000 May;18(10):2169-78. doi: 10.1200/JCO.2000.18.10.2169. J Clin Oncol. 2000. PMID: 10811682 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters